Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

Clinical Science

Volumn 120, Issue 6, 2011, Pages 239-250

  Lima Cabello, Elena ^a   García Mediavilla, María Victoria ^a,b   Miquilena Colina, María E ^b,c   Vargas Castrillón, Javier ^b,c   Lozano Rodríguez, Tamara ^b,c   Fernández Bermejo, Miguel ^d   Olcoz, José Luis ^b,e   González Gallego, Javier ^a,b   García Monzón, Carmelo ^b,c   Sánchez Campos, Sonia ^a,b  

^a UNIVERSITY OF LEÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^d San Pedro de Alcantara Hospital   (Spain)

^e Complejo Asistencial de León ^*  (Spain)

Author keywords

Chronic hepatitis C virus (HCV) infection; Inflammation; Lipogenesis; Liver X receptor (LXR); Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

CYCLOOXYGENASE 2; FATTY ACID SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIVER X RECEPTOR ALPHA; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C; HUMAN; HUMAN TISSUE; LIPOGENESIS; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEATOSIS; UPREGULATION;

ADULT; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION MEDIATORS; LIPOGENESIS; LIVER; MALE; MIDDLE AGED; ORPHAN NUCLEAR RECEPTORS; OXIDATIVE STRESS; UP-REGULATION;

EID: 79251639639     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100387     Document Type: Article

References (43)

1. McCullough, A. J. (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin. Liver Dis. 8, 521-533
2. Angulo, P. (2002) Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221-1231
3. Neuschwander-Tetri, B. A. (2005) Nonalcoholic steatohepatitis and the metabolic syndrome. Am. J. Med. Sci. 330, 326-335
4. Joseph, S. B., Laffitte, B. A., Patel, P. H., Watson, M. A., Matsukuma, K. E., Walczak, R., Collins, J. L., Osborne, T. F. and Tontonoz, P. (2002) Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 277, 11019-11025
5. Yoshikawa, T., Ide, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Matsuzaka, T., Yatoh, S., Kitamine, T.,Okazaki,H., Tamura, Y. et al. (2003) Cross-talk between peroxisome proliferators-activated receptor (PPAR) α and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signalling. Mol. Endocrinol. 17, 1240-1254
6. Neuschwander-Tetri, B.A. (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788
7. Day, C. P. (2006) From fat to inflammation. Gastroentrology 130, 207-210
8. Neuschwander-Tetri, B. A. (2010) Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH. Curr. Gastroenterol. Rep. 12, 49-56
9. Lonardo, A., Loria, P., Adinolfi, L. E., Carulli, N. and Ruggiero, G. (2006) Hepatitis C and steatosis: a reappraisal. J. Viral Hepat. 13, 73-80
10. Negro, F. and Sanyal, A. J. (2009) Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver Int. 29, 26-37
11. Gochee, P. A., Jonsson, J. R., Clouston, A. D., Pandeya, N., Purdie, D. M. and Powell, E. E. (2003) Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1. J. Gastroenterol. Hepatol. 18, 386-392
12. Sheikh, M. Y., Choi, J., Qadri, I., Friedman, J. E. and Sanyal, A. J. (2008) Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 47, 2127-2133
13. García-Mediavilla, M. V., Sánchez-Campos, S., González-Pérez, P., Gómez-Gonzalo, M., Majano, P. L., López-Cabrera, M., Clemente, G., García-Monzón, C. and González-Gallego, J. (2005) Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocytes-derived cells. J. Hepatol. 43, 606-613
14. Repa, J. J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J. M., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L. and Mangelsdorf, D. J. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14, 2819-2830
15. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J. and Tontonoz, P. (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219
16. Ogawa, D., Stone, J. F., Takata, Y., Blaschke, F., Chu, V. H., Towler, D. A., Law, R. E., Hsueh, W. A. and Bruemmer, D. (2005) Liver X receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ. Res. 96, e59-e67
17. Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M. and Whitington, P. F. (2004) Upregulation of osteopontin expression is involved in the development of non-alcoholic steatohepatitis in a dietary murine model. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G264-G273
18. García-Monzón, C., Majano, P. L., Zubia, I., Sanz, P., Apolinario, A. and Moreno-Otero, R. (2000) Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J. Hepatol. 32, 331-338
19. Núñez, O., Fernández-Martínez, A., Majano, P. L., Apolinario, A., Gómez-Gonzalo, M., Benedicto, I., López-Cabrera, M., Boscá, L., Clemente, G., García- Monzón, C. and Martín-Sanz, P. (2004) Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 53, 1665-1672
20. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
21. Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A. and Bacon, B. R. (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467-2474
22. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y. C., Torbenson, M. S., Unalp-Arida, A. et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321
23. Scheuer, P. J. (1991) Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13, 372-374
24. Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J. and Robertson, G. R. (2000) CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. 105, 1067-1075
25. Willy, P. J., Umesono, K., Ong, E. S., Evans, R. M., Heyman, R. A. and Mangelsdorf, D. J. (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9, 1033-1045
26. Repa, J. J. and Mangelsdorf, D. J. (2000) The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell. Dev. Biol. 16, 459-481
27. Larter, C. Z. and Farrell, G. C. (2006) Insulin resistance, adiponectin, cytokines and NASH:Which is the best target to treat? J. Hepatol. 44, 253-261
28. Schadinger, S. E., Bucher, N. L., Schreiber, B. M. and Farmer, S. R. (2005) PPARγ 2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288, E1195-E1205
29. Higuchi, N., Kato, M., Shundo, Y., Tajiri, H., Tanaka, M., Yamashita, N., Kohjima, M., Kotoh, K., Nakamuta, M., Takayanagi, R. and Enjoji, M. (2008) Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in non-alcoholic fatty liver disease. Hepatol. Res. 38, 1122-1129
30. Nakamuta, M., Fujino, T., Yada, R., Yada, M., Yasutake, K., Yoshimoto, T., Harada, N., Higuchi, N., Kato, M., Kohjima, M. et al. (2009) Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on non-alcoholic fatty liver disease. Int. J. Mol. Med. 23, 603-608
31. Wójcicka, G., Jamroz-Wiśniewska, A., Horoszewicz, K. and Bełtowski, J. (2007) Liver X receptors (LXRs)Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy. Hig. Med. Dosw. 61, 736-759
32. Kim, T.H., Kim, H., Park, J. M., Im, S. S., Bae, J. S., Kim, M. Y., Yoon, H. G., Cha, J. Y., Kim, K. S. and Ahn, Y. H. (2009) Interrelationship between liver X receptor α, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor γ , and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver. J. Biol. Chem. 29, 15071-15083
33. Moriishi, K., Mochizuki, R., Moriya, K., Miyamoto, H., Mori, Y., Abe, T., Murata, S., Tanaka, K., Miyamura, T. and Suzuki, T. (2007) Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 104, 1661-1666
34. Oem, J. K., Jackel-Cram, C., Li, Y. P., Zhou, Y., Zhong, J., Shimano, H., Babiuk, L. A. and Liu, Q. (2008) Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J. Gen. Virol. 89, 1225-1230
35. Mitsuyoshi, H., Yasui, K., Harano, Y., Endo, M., Tsuji, K., Minami, M., Itoh, Y., Okanoue, T. and Yoshikawa, T. (2009) Analysis of hepatic genes involved in the metabolism of fatty acids and iron in non-alcoholic fatty liver disease. Hepatol. Res. 39, 366-373
36. Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A. and George, J. (2004) Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 40, 46-54
37. Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J. and Gores, G. J. (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway. Hepatology 40, 185-194
38. Yang, X. P., Schaper, F., Teubner, A., Lammert, F., Heinrich, P. C., Matern, S. and Siewert, E. (2005) Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo. J. Hepatol. 43, 704-710
39. Ueki, K., Kondo, T., Tseng, Y. H. and Kahn, C. R. (2004) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. U.S.A. 101, 10422-10427
40. Persico, M., Capasso, M., Russo, R., Persico, E., Crocè, L., Tiribelli, C. and Iolascon, A. (2008) Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut 57, 507-515
41. Wang, Y. Y., Dahle, M. K., Agren, J., Myhre, A. E., Reinholt, F. P., Foster, S. J., Collins, J. L., Thiemermann, C., Aasen, A. O. and Wang, J. E. (2006) Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation. Shock 25, 141-146
42. Giannitrapani, L., Ingrao, S., Soresi, M., Florena, A. M., La Spada, E., Sandonato, L., D'Alessandro, N., Cervello, M. and Montalto, G. (2009) Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study. Ann. N.Y. Acad. Sci. 1155, 293-299
43. García-Monzón, C., Martín-Pérez, E., Iacono, O. L., Fernández-Bermejo, M., Majano, P. L., Apolinario, A., Larrañaga, E. and Moreno-Otero, R. (2000) Characterization of pathogenic and prognostic factors of non-alcoholic steatohepatitis associated with obesity. J. Hepatol. 33, 716-724